| 0 (0%) | 11-30 08:02 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 6.33 | 1-year : | 7.39 |
| Resists | First : | 5.42 | Second : | 6.33 |
| Pivot price | 4.44 |
|||
| Supports | First : | 4.43 | Second : | 3.81 |
| MAs | MA(5) : | 4.44 |
MA(20) : | 4.56 |
| MA(100) : | 3.4 |
MA(250) : | 3.23 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 78.1 |
D(3) : | 52.5 |
| RSI | RSI(14): 60.1 |
|||
| 52-week | High : | 5.78 | Low : | 1.84 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ACHV ] has closed below upper band by 15.0%. Bollinger Bands are 13.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5 - 5.01 | 5.01 - 5.03 |
| Low: | 4.5 - 4.52 | 4.52 - 4.54 |
| Close: | 4.81 - 4.84 | 4.84 - 4.86 |
Wed, 26 Nov 2025
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Wed, 26 Nov 2025
Achieve Life Sciences (NASDAQ:ACHV) Coverage Initiated at Citizens Jmp - MarketBeat
Tue, 25 Nov 2025
Citizens Initiates Coverage of Achieve Life Sciences (ACHV) with Market Outperform Recommendation - Nasdaq
Tue, 25 Nov 2025
Achieve Life Sciences (ACHV) Receives New 'Market Outperform' Rating from Citizens | ACHV Stock News - GuruFocus
Tue, 25 Nov 2025
New Analyst Forecast: $ACHV Given $19.0 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 53 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 46.7 (%) |
| Shares Short | 6,100 (K) |
| Shares Short P.Month | 4,390 (K) |
| EPS | -1.36 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.63 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -65.5 % |
| Return on Equity (ttm) | -161.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.98 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -41 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -3.61 |
| PEG Ratio | 0 |
| Price to Book value | 7.6 |
| Price to Sales | 0 |
| Price to Cash Flow | -6.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|